Related Experiment Video
Updated: May 7, 2026
06:12
Production of Double-stranded DNA Ministrings
Published on: February 29, 2016
12.3K
Cyclodextrins in non-viral gene delivery
1Division in Anatomy and Developmental Biology, Department of Oral Biology, College of Dentistry, Yonsei University, Seoul, Republic of Korea.
Biomaterials
|October 10, 2013
Summary
Cyclodextrins (CDs) show promise for gene delivery applications. This review explores their properties and use in developing non-viral gene carriers for future research.
Area of Science:
- Biotechnology
- Nanotechnology
- Polymer Science
Background:
- Cyclodextrins (CDs) are cyclic oligosaccharides with a unique amphiphilic structure.
- While extensively studied for drug delivery, their potential in gene delivery is less explored.
- CDs offer a versatile platform for developing novel gene delivery systems.
Purpose of the Study:
- To review the properties of cyclodextrins relevant to gene delivery.
- To summarize the current applications of CDs in non-viral gene carrier development.
- To highlight future research directions for CD-based gene delivery.
Main Methods:
- Literature review of cyclodextrin properties and applications in gene delivery.
- Analysis of existing studies on non-viral gene carriers incorporating cyclodextrins.
- Identification of key research gaps and future opportunities.
Main Results:
- Cyclodextrins possess favorable characteristics for gene complexation and delivery.
- CD-based non-viral vectors demonstrate potential for efficient gene transfection.
- Modifications of CDs enhance their gene delivery efficacy and safety profiles.
Conclusions:
- Cyclodextrins are emerging as significant tools for non-viral gene vector development.
- Further research into CD-based systems is crucial for advancing gene therapy.
- CDs are anticipated to play a key role in future gene delivery strategies.
Related Concept Videos
00:59Gene Therapy
22.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.3K
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
167
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
167